The Japanese Biochemical Society

[2P-281] Functions of tumor suppressor gene Mob1 in the uterus

Aono Yukari1, Nishio Miki1, To Yoko2, Maehama Tomohiko1, Kiyono Toru4, Katabuchi Hidetaka2, Tashiro Hironori3, Suzuki Akira1 (1.Div. of Mol. and Cell. Biol., Grad. Sch. of Med., Kobe Univ., 2.Dept. of Obst. and Gynecol., Faculty of Life Sci., Kumamoto Univ., 3.Dept. of Maternal-Newborn Nursing, Sch. of Health Sci., Kumamoto Univ., 4.Div. of Carcinogenesis and Cancer Prevention, Natl. Cancer Res. Inst.)

The 91th Annual Meeting of JBS

[2P-283] Suppression of tumorigenicity for mesothelioma: a novel approach to inhibit function of YAP

Nakano Naoko1, Kawamoto Rie1, Ishikawa Ryo1, Sano Keigo1, Fukuda Kazuo2, Shouda Takuji3, Hattori Takayuki4, Kurihara Masaaki3, Yamazaki Ryu2, Nakane Takahisa5, Okamoto Iwao2, Naito Mikihiko4, Itoh Susumu1 (1.Laboratory of Biochemistry, Showa Pharmaceutical University, 2.Laboratory of Pharmaceutical Organic Chemistry, Showa Pharmaceutical University, 3.Division of Organic Chemistry, National Institute of Health Sciences, 4.Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 5.Laboratory of Natural Products Chemistry, Showa Pharmaceutical University)

The 91th Annual Meeting of JBS

[2P-284] Contributions of apoptosis induction and JNK activation to enhanced cytotoxicity of arsenite and tetrandrine in human breast cancer cell line MDA-MB-231

Yu Bowen1,2, Yuan Bo1, Kiyomi Anna3, Tanaka Sachiko4, Hayashi Hideki1, Sugiura Munetoshi3, Hirano Toshihiko4, Pei Xiaohua2, Takagi Norio1 (1.Department of Applied Biochemistry, Tokyo University of Pharmacy & Life Sciences, 2.Beijing University of Chinese Medicine Third Affiliated Hospital, 3.Department of Drug Safety and Risk Management, Tokyo University of Pharmacy & Life Sciences, 4.Department of Clinical Pharmacology, Tokyo University of Pharmacy & Life Sciences)

The 91th Annual Meeting of JBS

[2P-285] Establishment and epitope mapping of cancer-specific anti-canine podoplanin mAb

Furusawa Yoshikazu1,2, Itai Shunsuke1,3, Yamada Shinji1, Kaneko Mika K.1, Kato Yukinari1 (1.Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Miyagi, Japan, 2.Zenoaq Resource Co.,Ltd., 3.Department of Oral and Maxillofacial surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University)

The 91th Annual Meeting of JBS